SCHEMBL23629044

SCHEMBL23629044

NC(=O)c1cnc2ccc(N3CCN(C(=O)CCOCCOCCNC(=O)O)CC3)cc2c1Nc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 11/20 0.49
▸ PDE4B Q07343 3/20 0.45
▸ GAA P10253 5/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ SLC2A1 P11166 1/20 0.42
▸ MAPT P10636 4/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MC4R P32245 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ PTK2B Q14289 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ CLK1 P49759 1/20 0.41
▸ GSK3A P49840 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ MTOR P42345 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23575565 0.91 CSF1R (0.51) CSF1RPDE4BGAAMEN1KMT2A
SCHEMBL23575759 0.91 CSF1R (0.47) CSF1RPDE4BGAAMEN1KMT2A
SCHEMBL23575470 0.88 CSF1R (0.51) CSF1RPDE4BGAAMEN1KMT2A
SCHEMBL23575367 0.82 CSF1R (0.53) CSF1RPDE4BMAPTLMNANPSR1
SCHEMBL23575445 0.78 PDE4B (0.46) CSF1RPDE4B
SCHEMBL23575650 0.77 CSF1R (0.57) CSF1RPDE4BMTOR
SCHEMBL23629075 0.77 CSF1R (0.56) CSF1RPDE4B
SCHEMBL23575654 0.76 CSF1R (0.59) CSF1RPDE4BMTOR
SCHEMBL23629074 0.74 CSF1R (0.62) CSF1RSLC2A1
SCHEMBL23200447 0.73 MEN1 (0.48) GAAMEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3846800-A1 COMPOUNDS FOR THE DEGRADATION OF BRD9 OR MTH1 C4 Therapeutics, Inc. (US) 2021-07-14 — — EP disclosed
Send feedback